AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 194 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,859,000 | +22.9% | 197,716 | 0.0% | 0.00% | – |
| Q2 2020 | $1,513,000 | +23.8% | 197,716 | 0.0% | 0.00% | – |
| Q1 2020 | $1,222,000 | -49.2% | 197,716 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $2,406,000 | +5.3% | 197,716 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $2,284,000 | +15.6% | 197,716 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $1,975,000 | -47.7% | 197,716 | -32.6% | 0.00% | 0.0% |
| Q1 2019 | $3,776,000 | -15.2% | 293,198 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $4,454,000 | -24.0% | 293,198 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $5,864,000 | +2.6% | 293,198 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $5,717,000 | -3.2% | 293,198 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $5,908,000 | -39.7% | 293,198 | -60.4% | 0.00% | -50.0% |
| Q4 2017 | $9,801,000 | -28.2% | 739,666 | 0.0% | 0.00% | -20.0% |
| Q3 2017 | $13,647,000 | +0.3% | 739,666 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $13,610,000 | -3.0% | 739,666 | +18.9% | 0.01% | -16.7% |
| Q1 2017 | $14,028,000 | -29.6% | 622,066 | +8.7% | 0.01% | -33.3% |
| Q4 2016 | $19,914,000 | +125.6% | 572,239 | +51.7% | 0.01% | +125.0% |
| Q3 2016 | $8,828,000 | +16.2% | 377,106 | +18.7% | 0.00% | 0.0% |
| Q2 2016 | $7,596,000 | +2.2% | 317,567 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $7,431,000 | -22.5% | 317,567 | 0.0% | 0.00% | -20.0% |
| Q4 2015 | $9,587,000 | -24.0% | 317,567 | 0.0% | 0.01% | -28.6% |
| Q3 2015 | $12,617,000 | +508.9% | 317,567 | +958.6% | 0.01% | +600.0% |
| Q2 2015 | $2,072,000 | +89.6% | 30,000 | +50.0% | 0.00% | 0.0% |
| Q1 2015 | $1,093,000 | -55.4% | 20,000 | -74.0% | 0.00% | 0.0% |
| Q3 2014 | $2,451,000 | -68.4% | 76,824 | -79.5% | 0.00% | -50.0% |
| Q2 2014 | $7,764,000 | +114.1% | 374,736 | +100.0% | 0.00% | 0.0% |
| Q1 2014 | $3,626,000 | -20.3% | 187,368 | 0.0% | 0.00% | -33.3% |
| Q4 2013 | $4,547,000 | +13.0% | 187,368 | 0.0% | 0.00% | +50.0% |
| Q3 2013 | $4,024,000 | -1.8% | 187,368 | +1.7% | 0.00% | -33.3% |
| Q2 2013 | $4,098,000 | +102.4% | 184,168 | +116.9% | 0.00% | +200.0% |
| Q1 2013 | $2,025,000 | +34.4% | 84,908 | 0.0% | 0.00% | 0.0% |
| Q3 2012 | $1,507,000 | +14.6% | 84,908 | 0.0% | 0.00% | 0.0% |
| Q2 2012 | $1,315,000 | – | 84,908 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $14 | 0.00% |